You are about to leave the Clinical Value website now.

Cancel

Looking to the Future – Blood-based Biomarkers for Liver Cancer Surveillance

reasearch on HCC

HCC Resources for Patients and Their Families

Woman putting on a head scarf while looking in the mirror standing in home interior, alopecia and cancer awareness.

HCC Monitoring and Surveillance Update – The Limbic

HCC monitoring and surveillance udpate

Patient-centric and ecosystem insights into hepatocellular carcinoma across Asia-Pacific – LEAP

Screenshot 2023 10 02 100520

In this white paper, insights on the liver ecosystem are uncovered, with the intention of facilitating action among various stakeholders to reduce liver cancer incidence and mortality in APAC. Read the whitepaper to find out more about the various active initiatives and recommendations for next steps. …

Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia

roche

In this whitepaper, HCC surveillance programs in Asia were analysed. The learnings from well established HCC surveillance programs, as well as the challenges in areas that have not implemented such programs have highlighted 7 priorities for implementing an HCC surveillance program….

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Untitled presentation

This white paper, which was developed by a group of experts in biomarker development, provides a framework on best practices to design, execute, and interpret biomarker studies for risk stratification, early detection, diagnosis, prognostication, and treatment response assessment in HCC.

Singal AG, Hoshida Y, Pinato DJ, Marrero J, Nault JC, Paradis V, Tayob N, Sherman M, Lim YS, Feng Z, Lok AS, Rinaudo JA, Srivastava S, Llovet JM, Villanueva A…